[Disorders of color perception in subtoxic and toxic digoxin and serum digoxin concentrations]. 1988

G Duncker, and H A Horst, and K D Kolenda, and F Schenck
Zentrum Operative Medizin II, Abteilung Ophthalmologie der Universität Kiel.

Using the Farnsworth-Munsell 100-hue test, investigations were carried out in 14 patients with subtoxic to toxic serum concentrations of digoxin (greater than 2.0 ng/ml) and 13 patients with subtoxic to toxic serum concentrations of digitoxin (greater than 30 ng/ml), in order to detect color vision deficiencies related to serum levels of digitalis. As compared to the control group (n = 24) the total error scores were significantly increased for both glycosides and all serum level ranges. No evidence was found indicating that digoxin and digitoxin influence color vision differently. The FM 100-hue test indicated definite improvements in the digoxin group within one day of discontinuing the glycosides, while the digitoxin group only started to normalize a week later. The results are discussed, taking the different pharmacokinetics of the two digitalis glycosides into account.

UI MeSH Term Description Entries
D003117 Color Vision Defects Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue. Achromatopsia,Color Blindness,Monochromatopsia,Color Blindness, Acquired,Color Blindness, Blue,Color Blindness, Green,Color Blindness, Inherited,Color Blindness, Red,Color Blindness, Red-Green,Color Vision Deficiency,Deutan Defect,Protan Defect,Tritan Defect,Achromatopsias,Acquired Color Blindness,Blindness, Color,Blue Color Blindness,Color Blindness, Red Green,Color Vision Defect,Color Vision Deficiencies,Defect, Color Vision,Defect, Deutan,Defects, Color Vision,Deficiencies, Color Vision,Deficiency, Color Vision,Green Color Blindness,Inherited Color Blindness,Red Color Blindness,Red-Green Color Blindness,Vision Defect, Color,Vision Defects, Color,Vision Deficiencies, Color,Vision Deficiency, Color
D003119 Color Perception Tests Type of vision test used to determine COLOR VISION DEFECTS. Color Perception Test,Perception Test, Color,Perception Tests, Color,Test, Color Perception,Tests, Color Perception
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Duncker, and H A Horst, and K D Kolenda, and F Schenck
March 1975, Kokyu to junkan. Respiration & circulation,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
April 1987, The American journal of psychiatry,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
November 1969, The New England journal of medicine,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
April 1992, Therapeutic drug monitoring,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
August 1976, British journal of clinical pharmacology,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
January 1975, Research communications in chemical pathology and pharmacology,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
October 1981, American journal of hospital pharmacy,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
August 1983, Annals of internal medicine,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
December 1987, The American journal of the medical sciences,
G Duncker, and H A Horst, and K D Kolenda, and F Schenck
February 1993, Journal of clinical pharmacy and therapeutics,
Copied contents to your clipboard!